Sign in
Taking peopleNo phase

MDW as a Novel Diagnostic Biomarker in LONS Among Preterm Neonates

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
1 Jul 2026
Expected to end
30 Jul 2027
Type of study
Observational, 2 groups
Treatments tested
  • MDW measurement
Record updated
15 September 2026

Who can take part

Age
73 hours to 28 days
Sex
Women and men

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Preterm neonates with gestational age <37 weeks
  • Neonates aged >72 hours of life at the time of enrollment
  • Neonates with clinical suspicion of late-onset neonatal sepsis, defined by the presence of one or more of the following:; Temperature instability (core temperature >38°C or <36°C); Respiratory distress or new-onset apnea; Feeding intolerance or poor feeding; Lethargy or irritability; Bradycardia or tachycardia; Hypotension; Unexplained clinical deterioration

Who cannot take part

  • Neonates with any of the following will be excluded from the study:; Early onset neonatal sepsis; Major congenital anomalies; Chromosomal abnormalities; Metabolic disorders; Severe perinatal asphyxia; Neonates with surgical conditions

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the diagnostic accuracy of monocyte distribution width (MDW) as a novel biomarker for late-onset neonatal sepsis in preterm neonates and to assess its association with disease severity and short-term clinical outcomes

The 2 groups in the trial

  • Sepsis group

    This group will include 30 preterm neonates with suspected LONS who fulfill the predefined clinical and laboratory criteria of clinical sepsis and/or have positive blood culture

    Treatment: MDW measurement

  • Control group

    It will include 30 neonates evaluated for suspected sepsis who will have negative blood cultures, will not fulfill the predefined clinical sepsis criteria, and will have an alternative non-infectious diagnosis.

    Treatment: MDW measurement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Monocyte Distribution Width as a Novel Diagnostic Biomarker in Late-Onset Sepsis Among Preterm Neonates
Record updated
15 September 2026